Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Incyte Corporation
Incyte Corporation
Dren Bio
Quetzal Therapeutics
AVM Biotechnology Inc
Children's Hospital of Philadelphia
Orca Biosystems, Inc.
Ohio State University Comprehensive Cancer Center
Kura Oncology, Inc.
Kura Oncology, Inc.
Dana-Farber Cancer Institute
Taiho Oncology, Inc.
Eastern Cooperative Oncology Group
Medical College of Wisconsin
AvenCell Therapeutics, Inc.
Daiichi Sankyo
Vironexis Biotherapeutics Inc.
Karolinska University Hospital
Dana-Farber Cancer Institute
Pfizer
Syndax Pharmaceuticals
Dana-Farber Cancer Institute
Kura Oncology, Inc.
Beijing GoBroad Hospital
University of Alabama at Birmingham
University of Chicago
University of Chicago
M.D. Anderson Cancer Center
Ossium Health, Inc.
Zhejiang University
Children's Hospital of Philadelphia
University of Miami
M.D. Anderson Cancer Center
Children's Hospital Medical Center, Cincinnati
Essen Biotech
Dana-Farber Cancer Institute
Stanford University
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
UNC Lineberger Comprehensive Cancer Center
Indiana University
Memorial Sloan Kettering Cancer Center
AstraZeneca
Sheba Medical Center
Cullgen (Shanghai),Inc
University of Colorado, Denver
Chinese University of Hong Kong
Dana-Farber Cancer Institute
Rennes University Hospital
Medical University of Gdansk